The ethics of access to patented biotech research tools from universities and other research institutions

Abstract

As universities and public research organizations increasingly partner with industry to fulfill their 'third mission' of innovation activities for economic and societal benefit, they have ethical obligations to ensure access to patented research tools, especially CRISPR–Cas9 technology.